ImmunityBio
The Scientist I, Analytical Development will join ImmunityBio's Analytical and Process Development team to develop, optimize, and validate bioassays supporting cell therapy projects. The role involves performing cell‑based assays, qualifying potency methods, maintaining laboratory equipment, and collaborating with cross‑functional teams to advance NK cell therapy products.
Headquarters
San Diego, California, United States
Company Size
501-1000 employees
Founded
2014
We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.
ImmunityBio Announces Resubmission of Supplemental BLA to the FDA for ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC with Papillary Disease Following Agency Review of Additional Data
3 days ago
Is It Time To Reassess ImmunityBio (IBRX) After Its Recent Share Price Surge
2 days ago
ImmunityBio’s Stock Sees a Huge Boost
3 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ImmunityBio.
ImmunityBio (NASDAQ:IBRX) Stock Price Up 3.2% - What's Next?
1 day ago
Cell Potency Analytical Development Lead
Artiva Biotherapeutics
Senior Scientist, Analytical Development
Bristol Myers Squibb
Research Bioassay Scientist
CSL Behring Australia
Scientist, Analytical Cell Line Engineering & Bioassay Development
BioLife Plasma Services
Analytical Development Scientist
Artiva Biotherapeutics
Senior Scientist I, Analytical Development, Biologics CMC
Exelixis